British Journal of Pharmacology · 2010 · 50 citations · 33 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisMolecular OncologyApoptosis PharmacologyOncology Pharmacology5-Lipoxygenase InhibitionAnnexin V AssaysAnticancer ActivityCancer Cell Proliferation InhibitionCell Viability AssaysCytotoxicity AssaysPoly Adp-ribose Polymerase InhibitorsPoly(adp-ribose) Polymerase Inhibition
BACKGROUND AND PURPOSE: Certain 5-lipoxygenase (5-LO) inhibitors exhibit anti-carcinogenic activities against 5-LO overexpressing tumour types and cultured tumour cells. It has been proposed therefore that 5-LO products significantly contribute to tumour cell proliferation. To date, the relationship between the inhibitory mechanisms of 5-LO inhibitors, which vary widely, and tumour cell viability has not been evaluated. This study addresses the anti-proliferative and cytotoxic potency of a number of 5-LO inhibitors with different inhibitory mechanisms in 5-LO-positive and 5-LO-negative tumour cells. EXPERIMENTAL APPROACH: Cell viability was measured by the WST-1 assay; cell proliferation was assessed using the bromodeoxyuridine (BrdU) incorporation assay. Cell death was analysed by annexin V staining, Western blot analysis of PARP (poly ADP-ribose polymerase) cleavage and a cytotoxicity assay. 5-LO product formation was quantified by a 5-LO activity assay. KEY RESULTS: The common 5-LO inhibitors AA-861, Rev-5901 and MK-886 induced cytotoxic and anti-proliferative effects in 5-LO-positive Capan-2 pancreatic cancer cells; BWA4C and CJ-13,610 only caused anti-proliferative effects, while zileuton failed to impair cell viability. Moreover, the concentrations of the 5-LO inhibitors required to induce anti-proliferation and cytotoxicity highly exceeded those for suppression of 5-LO. Supplementation with mitogenic 5-LO products failed to protect Capan-2 cells from the effects of 5-LO inhibitors. Finally, the cytotoxic and anti-proliferative 5-LO inhibitors also potently reduced the viability of 5-LO-deficient tumour cell lines (HeLa, Panc-1 and U937). CONCLUSIONS AND IMPLICATIONS: Certain 5-LO inhibitors cause cytotoxic and anti-proliferative effects independently of suppression of 5-LO activity. Thus, the role of 5-LO overexpression in tumour cell viability remains unclear and requires further elucidation.
33
Tanihiro Yoshimoto, Chieko Yokoyama, Ochi Kenkichi et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1982 · 249 citations
5‐lipoxygenase‐activating protein is an arachidonate binding protein
Joseph A. Mancini, Mark Abramovitz, Martha E. Cox et al. · FEBS Letters · 1993 · 228 citations · Full text